26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Glycosylated Amino Acid Synthesis 193<br />

RO<br />

RO<br />

OR<br />

O<br />

O<br />

X<br />

RO<br />

RO<br />

Ac<br />

X = Br,Cl<br />

O<br />

OR<br />

O<br />

Ac<br />

O<br />

O<br />

Oxocarbeniumion<br />

RO RO<br />

OR<br />

O<br />

O<br />

O<br />

Ac<br />

Acyloxoniumion<br />

Nu –<br />

RO RO<br />

RO RO<br />

OR<br />

O<br />

Ac<br />

O<br />

O<br />

OR<br />

O<br />

Nu<br />

1,2-trans-Glycoside<br />

O<br />

O<br />

Ac Nu<br />

Orthoester<br />

Fig. 3. Glycosidation pathways with a participating group in the 2-position.<br />

pivaloyl group or a benzoyl group, which can delocalize the positive charge more<br />

efficiently.<br />

Glycosylation without a neighboring effect will result in the formation of both<br />

1,2-trans as well as 1,2-cis glycosides. The in situ anomerization procedure is<br />

the most common method for the synthesis of 1,2-cis glycosides. The soluble<br />

catalyst facilitates the rapid interconversion between the �- and�-glycosyl<br />

bromides via contact ion pairs (Fig. 4). The�-bromide is stabilized by the<br />

anomeric effect, and the more reactive �-bromide is present only in low concentrations.<br />

The higher reactivity of the �-bromide and the higher energy barrier for<br />

attack on the �-bromide leads to the selective formation of the 1,2-cis glycoside<br />

from the �-bromide. It is important to use a solvent of low polarity in order to<br />

prevent the dissociation of the ion pairs with concomitant loss of stereoselectivity.<br />

The most widely used approaches in the synthesis of the O-glycosylated<br />

amino acids, Koenigs-Knorr, activation of anomeric acetate, trichloroacetimidate,<br />

and thioglycosides will be explained in detail.<br />

RO RO<br />

OR<br />

O<br />

Y<br />

1,2-trans<br />

β−glycoside<br />

Nu<br />

Nu –<br />

Slow<br />

RO RO<br />

OR<br />

O<br />

Y<br />

X<br />

RO RO<br />

OR<br />

OR<br />

RO<br />

RO<br />

O<br />

Y<br />

RO<br />

RO<br />

O<br />

Y<br />

X<br />

X<br />

α−contaction-pair β−contaction-pair<br />

X = Br or Cl; Y = BnO or N 3<br />

OR<br />

O<br />

Y<br />

X<br />

Nu –<br />

Fast<br />

RO RO<br />

OR<br />

O<br />

Y<br />

Nu<br />

1,2-cis<br />

α−glycoside<br />

Fig. 4. Glycosidation pathways with a nonparticipating group in the 2-position.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!